In DM, Treg cells from peripheral blood are characterized by the low CTLA-4 expression and the impaired function [67], whereas in PM and IBM models, the addition of Treg cells in vitro reduces CD8 + T cell myolysis [68]. This evidence concerns the gene CD8A and dermatomyositis.